Trazium esilate

This classification denotes an antidepressant agent with the molecular formula C17H13ClN3O.C2H5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1PO9LWW5IN, chemically known as 1-(p-chlorophenyl)-1,2-dihydro-1-hydroxy-as-triazino(6,1-a)isoquinolin-5-ium ethanesulfonate but generally known as trazium esilate, which bears US NIH Compound Identifier 72166. European Medicines Agency schedules Trazium esilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11223MIG. The term TRAZIUM ESILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). Most nations schedule trazium esilate under HS 29339990 and SITC 51577. As of Q4 2014, TRAZIUM ESILATE remains the US FDA Preferred Term for this commodity. Trazium esilate bears US NLM identifiers UMLS ID C2348815 and NCI Concept Code C72873. SMILES: Clc1ccc(C2(O)N=CN[n]3c2c2c(cc3)cccc2)cc1.S(=O)(=O)(O)CC.